← Back to headlines
Annovis Bio Regains NYSE Listing Compliance
Annovis Bio, a clinical-stage pharmaceutical company, has successfully regained compliance with the New York Stock Exchange's listing requirements.
26 May, 12:22 — 26 May, 12:22
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Latvian Business Developments: Schwenk Plant and Rūjienas Saldējums Expansion
just now
LSM last year - 299 thousand euros in losses and investments in technology
just now
Over 12,000 Ghanaians Complete One Million Coders Programme
13m ago